Three things to know:
1. At present, all Ebola treatments in clinical development are targeted toward a specific Ebola species.
2. Researchers found that a single dose of the new combination treatment proved effective against the Bundibugyo, Sudan and Zaire Ebola strains in nonhuman primates.
3. The cocktail also outperformed the single antibody treatment in protecting guinea pigs against Ebola.
“Our experimental drug can protect against all forms of Ebola known to harm people, suggesting that it will continue to protect people if the Ebola viruses evolve over time,” Thomas Geisbert, PhD, an Ebola researcher and professor of microbiology and immunology at The University of Texas Medical Branch in Galveston, said in a press release.
More articles on clinical leadership & infection control:
NorthShore to offer 10,000 primary care patients DNA testing services
Nebraska children’s hospital cleared of some allegations
CDC: E. coli outbreak linked to romaine is over
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.